Jain Rita — SEC Form 4 filings
SEC reporting owner CIK 1707797. 18 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2024-06-17 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| First Tracks Biotherapeutics, Inc. (TRAX) | Director | 4 | — | — | 15 |
| ANAPTYSBIO, INC (ANAB) | Director | 4 | — | — | 10 |
| Avalo Therapeutics, Inc. (AVTX) | Director | 6 | — | — | 6 |
| Celldex Therapeutics, Inc. (CLDX) | Director | 3 | — | — | 3 |
| SAB Biotherapeutics, Inc. (SABS) | Director | 1 | — | — | 1 |
Form 4 filings — Jain Rita
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | Avalo Therapeutics, Inc. (AVTX) | Grant/award (A): 1,080 (derivative) @ $15.04 | EDGAR |
| 2026-06-29 | 4 | Celldex Therapeutics, Inc. (CLDX) | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | First Tracks Biotherapeutics, Inc. (TRAX) | Option exercise (M): 7,330 @ $0 · Option exercise (M): 6,030 (derivative) @ $0 · Option exercise (M): 1,300 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4/A | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/award (A): 2,500 (derivative) @ $0 · Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Avalo Therapeutics, Inc. (AVTX) | Grant/award (A): 20,100 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/award (A): 10,600 (derivative) @ $0 · Grant/award (A): 8,015 (derivative) @ $0 · Grant/award (A): 16,510 (derivative) @ $0 · Grant/award (A): 16,510 (derivative) @ $0 · Grant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 1,300 (derivative) @ $0 · +2 more | EDGAR |
| 2026-04-01 | 4 | Avalo Therapeutics, Inc. (AVTX) | Grant/award (A): 1,339 (derivative) @ $12.13 | EDGAR |
| 2026-01-08 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 4,000 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | SAB Biotherapeutics, Inc. (SABS) | Grant/award (A): 240,000 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Avalo Therapeutics, Inc. (AVTX) | Grant/award (A): 1,043 (derivative) @ $14.74 | EDGAR |
| 2025-10-02 | 4 | Avalo Therapeutics, Inc. (AVTX) | Grant/award (A): 1,572 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | Avalo Therapeutics, Inc. (AVTX) | Grant/award (A): 40,200 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 7,330 @ $0 · Option exercise (M): 1,300 (derivative) @ $0 · Option exercise (M): 6,030 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Celldex Therapeutics, Inc. (CLDX) | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 16,510 (derivative) @ $0 · Grant/award (A): 6,030 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 4,534 @ $0 · Option exercise (M): 3,234 (derivative) @ $0 · Option exercise (M): 1,300 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Celldex Therapeutics, Inc. (CLDX) | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1707797 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →